FDA Minimizes Vision for Drug It Touted as Possible Autism Treatment
Date postedMarch 11, 2026
News,
Nearly six months ago, federal health officials gathered at the White House with President Donald Trump and vowed to "go bold" on autism. They sketched out plans for what they described as an "exciting treatment" for children with the condition — a decades-old drug, leucovorin, newly recast as a potential breakthrough.
"Hundreds of thousands of kids, in my opinion, will benefit," said Food and Drug Administration Commissioner Marty Makary at the time.
But the administration is scaling back that vision. FDA announced Tuesday that it will expand approval for leucovorin, but only for a separate condition that some people with autism also have — not for autism itself.
Please select this link to read the complete article from The Washington Post.